Trial Profile
The effect of body weight on trough concentrations of DOACs in patients.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 02 Jan 2018
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Edoxaban (Primary) ; Rivaroxaban (Primary)
- Indications Deep vein thrombosis; Embolism; Pulmonary embolism; Venous thromboembolism
- Focus Pharmacokinetics
- 02 Jan 2018 New trial record